01 1Cipla
01 1NEVIRAPINE HEMIHYDRATE USP
01 1India
01 1Active
01 1Complete
GDUFA
DMF Review : Complete
Rev. Date : 2014-06-23
Pay. Date : 2014-04-16
DMF Number : 19753
Submission : 2008-04-03
Status : Active
Type : II
20
Cipla Ltd, based in India, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.
One of their notable products is NEVIRAPINE HEMIHYDRATE USP, with a corresponding US DMF Number 19753.
Remarkably, this DMF maintains an Active status since its submission on April 03, 2008, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of June 23, 2014, and payment made on April 16, 2014, indicating their dedication to facilitating drug approvals, Categorized as Type II
